These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8643664)

  • 21. Specificity of action of a herpes virus VP16/tetracycline-dependent trans-activator in mammalian cell cultures.
    Magalini A; Ferrari F; Savoldi G; Ingrassia R; Albertini A; Pollio G; Patrone C; Maggi A; Di Lorenzo D
    DNA Cell Biol; 1995 Aug; 14(8):665-71. PubMed ID: 7646813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Constitutive N-myc gene expression inhibits trkA mediated neuronal differentiation.
    Bogenmann E; Torres M; Matsushima H
    Oncogene; 1995 May; 10(10):1915-25. PubMed ID: 7761093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. v-Myc is invariably required to sustain rapid proliferation of infected cells but in stable cell lines becomes dispensable for other traits of the transformed phenotype.
    Tikhonenko AT; Black DJ; Linial ML
    Oncogene; 1995 Oct; 11(8):1499-508. PubMed ID: 7478574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel function for Myc: inhibition of C/EBP-dependent gene activation.
    Mink S; Mutschler B; Weiskirchen R; Bister K; Klempnauer KH
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6635-40. PubMed ID: 8692870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of telomerase activity in v-myc-transformed avian cells.
    Falchetti ML; Falcone G; D'Ambrosio E; Verna R; Alemà S; Levi A
    Oncogene; 1999 Feb; 18(7):1515-9. PubMed ID: 10050888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective repression of myoD transcription by v-Myc prevents terminal differentiation of quail embryo myoblasts transformed by the MC29 strain of avian myelocytomatosis virus.
    La Rocca SA; Vannucchi S; Pompili M; Pinney DF; Emerson CP; Grossi M; Tatò F
    Oncogene; 2002 Jul; 21(31):4838-42. PubMed ID: 12101422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors.
    Klein RL; Meyer EM; Peel AL; Zolotukhin S; Meyers C; Muzyczka N; King MA
    Exp Neurol; 1998 Apr; 150(2):183-94. PubMed ID: 9527887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The v-myc oncogene.
    Lee CM; Reddy EP
    Oncogene; 1999 May; 18(19):2997-3003. PubMed ID: 10378695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tetracycline-mediated regulation of gene expression within the human cytomegalovirus genome.
    McVoy MA; Mocarski ES
    Virology; 1999 Jun; 258(2):295-303. PubMed ID: 10366566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term inducible expression in striatal neurons from helper virus-free HSV-1 vectors that contain the tetracycline-inducible promoter system.
    Gao Q; Sun M; Wang X; Zhang GR; Geller AI
    Brain Res; 2006 Apr; 1083(1):1-13. PubMed ID: 16545782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. V-myc immortalizes human neural stem cells in the absence of pluripotency-associated traits.
    Pino-Barrio MJ; García-García E; Menéndez P; Martínez-Serrano A
    PLoS One; 2015; 10(3):e0118499. PubMed ID: 25764185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conditional cell transformation by doxycycline-controlled expression of the MC29 v-myc allele.
    Oberst C; Hartl M; Weiskirchen R; Bister K
    Virology; 1999 Jan; 253(2):193-207. PubMed ID: 9918878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
    Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
    Liebermann DA; Hoffman B
    Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenovirus-mediated inducible gene expression through tetracycline-controllable transactivator with nuclear localization signal.
    Yoshida Y; Hamada H
    Biochem Biophys Res Commun; 1997 Jan; 230(2):426-30. PubMed ID: 9016796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The function of inducible promoter systems in F9 embryonal carcinoma cells.
    Miller K; Rizzino A
    Exp Cell Res; 1995 May; 218(1):144-50. PubMed ID: 7737354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EGF receptor activity and mitogenic response of Balb/3T3 cells expressing Ras and Myc oncogenes. EGF receptor activity in oncogene transformed cells.
    Gopas J; Ono M; Princler G; Smith MR; Tainsky MA; Siddiqui MA; Wishniak O; Segal S; Kuwano M; Kung HF
    Cell Mol Biol; 1992 Sep; 38(6):605-14. PubMed ID: 1303308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. c-MYC repression of promoter activity through core promoter elements.
    Lucas JM; Wilkie NM; Lang JC
    Biochem Biophys Res Commun; 1993 Aug; 194(3):1446-52. PubMed ID: 8352803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters.
    Pluta K; Luce MJ; Bao L; Agha-Mohammadi S; Reiser J
    J Gene Med; 2005 Jun; 7(6):803-17. PubMed ID: 15655804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line.
    Himelstein BP; Lee EJ; Sato H; Seiki M; Muschel RJ
    Oncogene; 1997 Apr; 14(16):1995-8. PubMed ID: 9150367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.